Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer

被引：6
|
作者：
Morganti, Stefania [1 ,2 ,3 ,4 ,5 ]
Tolaney, Sara M. [1 ,2 ,6 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA
[2] Dana Farber Brigham Canc Ctr, Breast Oncol Program, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Broad Inst & Harvard, Boston, MA USA
[5] Univ Milan, Ist Europeo Oncol, Dept Oncol & Hemato Oncol, Milan, Italy
[6] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 01期
关键词：
TNBC; Breast cancer; Immunotherapy; Biomarkers; PDL1; Immune checkpoint inhibitors; PEMBROLIZUMAB PLUS CHEMOTHERAPY; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; DOUBLE-BLIND; PLACEBO; ATEZOLIZUMAB; PACLITAXEL; MELANOMA; TNBC;
D O I：
10.1016/j.hoc.2022.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：133 / 150
页数：18
相关论文
共 50 条
  • [21] Recurrent Early-Stage Triple-Negative Breast Cancer
    Adonizio, Christian S.
    Grano, Genorosa
    Sharon, Kanu
    Rose, Lewis
    Zibelli, Allison
    Miller-Samuel, Susan
    Morris, Gloria J.
    SEMINARS IN ONCOLOGY, 2010, 37 (05) : 419 - 428
  • [22] TILs in early-stage triple-negative breast cancer
    Artemyeva, A.
    Chuglova, D.
    Kushnarev, V.
    Paltuev, R.
    Demina, N.
    Kudaybergenova, A.
    VIRCHOWS ARCHIV, 2019, 475 : S67 - S67
  • [23] The Use of Immunotherapy in Triple-Negative Breast Cancer
    Schmid, Peter
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 770 - 773
  • [24] Advances in immunotherapy for triple-negative breast cancer
    Yang Liu
    Yueting Hu
    Jinqi Xue
    Jingying Li
    Jiang Yi
    Jiawen Bu
    Zhenyong Zhang
    Peng Qiu
    Xi Gu
    Molecular Cancer, 22
  • [25] Prospects of Immunotherapy for Triple-Negative Breast Cancer
    Qiu, Dan
    Zhang, Guijuan
    Yan, Xianxin
    Xiao, Xinqin
    Ma, Xinyi
    Lin, Shujun
    Wu, Jieyan
    Li, Xinyuan
    Wang, Wandi
    Liu, Junchen
    Ma, Yi
    Ma, Min
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [26] Role of Immunotherapy in the Treatment of Triple-Negative Breast Cancer: A Literature Review
    Patel, Khushbu K.
    Hassan, Danial
    Nair, Shaalina
    Tejovath, Sreedevi
    Kahlon, Simranjit S.
    Peddemul, Aishwarya
    Sikandar, Rabia
    Mostafa, Jihan A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [27] Early- and late-stage breast cancer in a managed care setting in relation to mammography screening
    Rolnick, SJ
    O'Connor, PJ
    Jackson, JM
    Boyle, RG
    Pronk, NP
    Loes, LM
    CANCER DETECTION AND PREVENTION, 1998, 22 (06): : 495 - 498
  • [28] Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
    Pinzon-Charry, A.
    Ho, C. S. K.
    Maxwell, T.
    McGuckin, M. A.
    Schmidt, C.
    Furnival, C.
    Pyke, C. M.
    Lopez, J. A.
    BRITISH JOURNAL OF CANCER, 2007, 97 (09) : 1251 - 1259
  • [29] Adjuvant Chemotherapy in early stage Triple-Negative Breast Cancer Patients
    Pfeiler, G.
    Koenigsbergt, R.
    Natter, C.
    Jahn-Kuch, D.
    Hudec, M.
    Zeilinger, R.
    Dittrich, C.
    Singer, C.
    ONKOLOGIE, 2010, 33 : 26 - 26
  • [30] The landscape of systemic therapy for early stage triple-negative breast cancer
    Lu, Jin-Yu
    Soto, Alvaro Alvarez
    Anampa, Jesus D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (11) : 1291 - 1303
12345